Senzime
Pre-clinicalSenzime is a global medical device company with the mission of safeguarding every patient's journey, from anesthesia to recovery. Developers of TetraGraph, an innovative quantitative train-of-four (TOF) monitoring system.
Founded
2004
Focus
Medical Devices
About
Senzime is a global medical device company with the mission of safeguarding every patient's journey, from anesthesia to recovery. Developers of TetraGraph, an innovative quantitative train-of-four (TOF) monitoring system.
Funding History
1Total raised: $8.2M
IPO$8.2MAvanza BankJun 28, 2019
Company Info
TypePrivate
Founded2004
LocationUppsala, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile